🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial is studying eflornithine and sulindac to se...
Status
Completed
Location
University of California Medical Center At Irvine-Orange Campus
Start Date
1998-07
Trial ID
NCT00118365
Treatments Being Tested
This randomized phase II trial studies how well giving celecoxib with or wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2001-12-13
Trial ID
NCT00033371
Treatments Being Tested
The investigators hypothesize that the combination of eflornithine and suli...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-08-23
Trial ID
NCT01349881
The purpose of this randomized, double-blind, Phase III trial is to determi...
Status
Completed
Location
University of California San Diego
Start Date
2013-10
Trial ID
NCT01483144
Treatments Being Tested
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to pr...
Status
Completed
Location
University of Texas - MD Anderson Cancer Center
Start Date
1998-06-19
Trial ID
NCT00006079
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Urology Associates
Start Date
1999-02
Trial ID
NCT00003814
Treatments Being Tested
This early phase I trial studies brain tumor (glioma) metabolism in respons...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2023-10-01
Trial ID
NCT05717153
This study is a multicenter, double-blind, placebo-controlled, 2:1 randomly...
Status
Completed
Location
Riley Hospital for Children
Start Date
2015-04
Trial ID
NCT02384889
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as eflornithine, work in differ...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2001-11
Trial ID
NCT00086736
Treatments Being Tested
The purpose of this study is to evaluate whether regular use of eflornithin...
Status
Completed
Location
Multiple Locations
Start Date
2004-11-30
Trial ID
NCT00152048
Treatments Being Tested